Cambridge-based neural engineering company building AI-powered neural interfaces and software to read and modulate nervous-system signals for precision medicine.
More about BIOS Health
BIOS Health Ltd is a UK-based neural engineering company founded in 2015 by graduates from Cambridge University. The company specializes in AI-powered neural interfaces and software designed to interpret and modulate neural signals, focusing on treating chronic diseases, particularly cardiac conditions. Headquartered in Cambridge, BIOS Health aims to innovate in digital health treatments by utilizing real-time neural insights for personalized precision medicine. The company's core offering is the Neural Platform, which includes implantable neural interfaces for real-time data analysis, AI software for interpreting neural signals, and wearable health monitoring tools. Key technologies such as BIOS Neural Dosing personalize neuromodulation therapies quickly, while the Autonomic Therapy Initiative focuses on neural control of the heart to combat cardiovascular diseases. BIOS Health is actively expanding, with plans for a Precision Medicine Center in California and ongoing hiring efforts in Cambridge and Montreal.